Review article: Lack of effect of opiates in the treatment of acute cardiogenic pulmonary oedema

EMA - Emergency Medicine Australasia

Volumn 20, Issue 5, 2008, Pages 384-390

  Sosnowski, Marcin A ^a,b  

^a Whangan District Health Board   (New Zealand)

^b Wangani Hospital   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BENZODIAZEPINE DERIVATIVE; CAPTOPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; LOOP DIURETIC AGENT; MORPHINE; NALOXONE; NARCOTIC AGENT; OPIATE DERIVATIVE;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ANXIETY; ARTERIAL OXYGEN TENSION; ASSISTED VENTILATION; BLOOD PRESSURE; BREATHING MECHANICS; BREATHING RATE; CARDIOGENIC PULMONARY EDEMA; CARDIOPULMONARY HEMODYNAMICS; CLINICAL TRIAL; COCHRANE LIBRARY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EMBASE; EMERGENCY MEDICINE; HEART FAILURE; HEART OUTPUT; HEART RATE; HUMAN; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG EDEMA; MEDICAL PRACTICE; MEDLINE; META ANALYSIS; MORBIDITY; MORTALITY; OXYGEN SATURATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSE RATE; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VEIN BLOOD FLOW;

ACUTE DISEASE; ANTI-ANXIETY AGENTS; EVIDENCE-BASED MEDICINE; HEART DISEASES; HEART FAILURE; HUMANS; MORPHINE; NARCOTICS; PULMONARY EDEMA; RISK FACTORS; VASODILATION;

EID: 54049123711     PISSN: 17426731     EISSN: 17426723     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2008.01113.x     Document Type: Review

References (21)

1. Sacchetti A, Ramoska E, Moakes ME, McDermott P, Moyer V. Effect of ED management on ICU use in acute pulmonary edema. Am. J. Emerg. Med. 1999 17 : 571 4.
2. Hoel BL, Bay G, Refsum HE. The effects of morphine on the arterial and mixed venous blood gas state and on the hemodynamics in patients with clinical pulmonary congestion. Acta Med. Scand. 1971 190 : 549 54.
3. The Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur. Heart J. 2005 26 : 384 416.
4. Lee G, DeMaria AN, Amsterdam EA. et al. Comparative effects of morphine, meperidine and pentazocine on cardiocirculatory dynamics in patients with acute myocardial infarction. Am. J. Med. 1976 60 : 949 55.
5. Mattu A. et al. Emedicine topic - Pulmonary Edema - Cardiogenic. [Cited 10 Jun 2005.] Available from URL: http://www.emedicine.com/med/topic1955.htm
6. Mosesso VN Jr, Dunford J, Blackwell T, Griswell JK. Prehospital therapy for acute congestive heart failure: state of the art. Prehosp. Emerg. Care 2003 7 : 13 23.
7. Murdoch DR, McMurray JJ. Acute heart failure: a practical guide to management. Hosp. Med. 2000 61 : 725 9.
8. Pugsley MK. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol. Ther. 2002 93 : 51 75.
9. Grendahl H, Andersen A, Muller C. The effect of intravenous morphine in patients with mitral valvular disease and congestive heart failure. Acta Med. Scand. 1973 1-2 : 69 74.
10. Vismara LA, Leaman DM, Zelis R. The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 1976 54 : 335 7.
11. Leaman DM, Levenson L, Zelis R, Shiroff R. Effect of morphine on splanchnic blood flow. Br. Heart J. 1978 40 : 569 71.
12. Timmis AD, Rothman MT, Henderson MA, Geal PW, Chamberlain DA. Haemodynamic effects of intravenous morphine in patients with acute myocardial infarction complicated by severe left ventricular failure. Br. Med. J. 1980 280 : 980 2.
13. Hoffman JR, Reynolds S. Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. Chest 1987 92 : 586 93.
14. Chambers JA, Baggoley CJ. Pulmonary oedema - prehospital treatment. Caution with morphine dosage. Med. J. Aust. 1992 157 : 326 8.
15. Beltrame JF, Zeitz CJ, Unger SA et al. Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema. J. Card. Fail. 1998 4 : 271 9.
16. Fiutowski M, Waszyrowski T, Krzeminska-Pakula M, Kasprzak JD. Wpływ leczenia farmakologicznego na rokowanie krótkoterminowe i długoterminowe u pacjentów po incydencie kardiogennego obrzȩku, płuc (Relationship of medical therapy and survival in patients after acute cardiogenic pulmonary oedema). Polski Przeglad Kardiologiczny 2003 5 : 409 14.
17. Bruns BM, Dieckmann R, Shagoury C, Dingerson A, Swartzell C. Safety of pre-hospital therapy with morphine sulfate. Am. J. Emerg. Med. 1992 10 : 53 7.
18. Adams FB Jr. Use of morphine sulfate for acute pulmonary edema [Comment]. Am. Fam. Physician 1997 55 : 1561.
19. Klinefelter H. Morphine for pulmonary edema [Letter]. JAMA 1974 229 : 638.
20. Pang D, Keenan SP, Cook DJ, Sibbald WJ. The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. Chest 1998 114 : 1185 92.
21. Cotter G, Metzkor E, Kaluski E et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998 351 : 389 93.